Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

Journal of the American College of Cardiology

Volumn 57, Issue 7, 2011, Pages 821-828

  Iles, Leah ^a   Pfluger, Heinz ^a   Lefkovits, Lisa ^a   Butler, Michelle J ^a   Kistler, Peter M ^a   Kaye, David M ^a   Taylor, Andrew J ^a  

^a NONE

Author keywords

arrhythmia; cardiomyopathy; heart arrest; magnetic resonance imaging

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE THERAPY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN DEATH;

CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79851476269     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.062     Document Type: Article

References (34)

1. W.G. Stevenson, L.W. Stevenson, H.R. Middlekauff, and L.A. Saxon Sudden death prevention in patients with advanced ventricular dysfunction Circulation 88 1993 2953 2961 (Pubitemid 23360223)
2. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158 (Pubitemid 38637995)
3. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
4. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
5. M.B. McClellan, and S.R. Tunis Medicare coverage of ICDs N Engl J Med 352 2005 222 224 (Pubitemid 40110810)
6. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480 (Pubitemid 41400921)
7. A.E. Buxton, K.L. Lee, and G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157 (Pubitemid 47375017)
8. S.M. Al-Khatib, G.D. Sanders, and J.T. Bigger Preventing tomorrow's sudden cardiac death today Part I: current data on risk stratification for sudden cardiac death Am Heart J 153 2007 941 950 (Pubitemid 46809840)
9. R.G. Assomull, S.K. Prasad, and J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985 (Pubitemid 44738448)
10. K.C. Wu, R.G. Weiss, and D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421 (Pubitemid 351826874)
11. H. Hsia, and F. Marchlinski Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy Pacing Clin Electrophysiol 25 2002 1114 1127 (Pubitemid 34828067)
12. T.-J. Wu, J.J.C. Ong, and C. Hwang Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry J Am Coll Cardiol 32 1998 187 196 (Pubitemid 28351061)
13. S. Nazarian, D.A. Bluemke, and A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825 (Pubitemid 41641676)
14. J.C.C. Moon, E. Reed, and M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264 (Pubitemid 38757595)
15. J.A. McCrohon, J.C. Moon, and S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59 (Pubitemid 36859020)
16. A.J. Taylor, N. Al-Saadi, H. Abdel-Aty, J. Schulz-Menger, D.R. Messroghli, and M.G. Friedrich Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging Circulation 109 2004 2080 2085 (Pubitemid 38620215)
17. W. Grimm, J.u. Hoffmann, H.-H. Muller, and B. Maisch Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30% J Am Coll Cardiol 39 2002 780 787 (Pubitemid 34185323)
18. B.G. Hook, and F.E. Marchlinski Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy J Am Coll Cardiol 17 1991 985 990
19. F.E. Marchlinski, C.D. Gottlieb, and B. Sarter ICD data storage: value in arrhythmia management Pacing Clin Electrophysiol 16 1993 527 534 (Pubitemid 23128683)
20. D.J. Callans, B.G. Hook, and F.E. Marchlinski Use of bipolar recordings from patch-patch and rate sensing leads to distinguish ventricular tachycardia from supraventricular rhythms in patients with implantable cardioverter defibrillators Pacing Clin Electrophysiol 14 1991 1917 1922
21. R. Lo, and H.H. Hsia Ventricular arrhythmias in heart failure patients Cardiol Clin 26 2008 381 403 (Pubitemid 351758982)
22. H.H. Hsia, D.J. Callans, and F.E. Marchlinski Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia Circulation 108 2003 704 710 (Pubitemid 36999255)
23. F.M. Bogun, B. Desjardins, and E. Good Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate J Am Coll Cardiol 53 2009 1138 1145
24. A.S. Adabag, B.J. Maron, and E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374 (Pubitemid 351443083)
25. J.A. Ezekowitz, B.H. Rowe, and D.M. Dryden Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction Ann Intern Med 147 2007 251 262 (Pubitemid 351664582)
26. C.J.W. Borleffs, A.A.M. Wilde, M.J.M. Cramer, E. Wever, and A. Mosterd Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Netherlands Heart J 15 2007 129
27. D.B. Mark, C.L. Nelson, and K.J. Anstrom Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Circulation 114 2006 135 142 (Pubitemid 44420745)
28. S.M. Al-Khatib, K.J. Anstrom, and E.L. Eisenstein Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II Ann Intern Med 142 2005 593 600 (Pubitemid 40529955)
29. J. Zwanziger, W.J. Hall, and A.W. Dick The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II J Am Coll Cardiol 47 2006 2310 2318 (Pubitemid 43795065)
30. L.W. Stevenson, and A.S. Desai Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure J Cardiac Fail 12 2006 407 412 (Pubitemid 46110776)
31. W.C. Levy, K.L. Lee, and A.S. Hellkamp Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
32. R.Y. Kwong, A.K. Chan, and K.A. Brown Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743 (Pubitemid 43947991)
33. R. Rubinshtein, J.F. Glockner, and S.R. Ommen Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
34. L. Iles, H. Pfluger, and A. Phrommintikul Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580